Keyphrases
TIGIT
100%
Neuroblastoma
100%
Nectin-2
100%
Single-cell RNA Sequencing (scRNA-seq)
100%
Integrative Analysis
100%
Immunomodulatory
50%
Complete Response
50%
Programmed Death-ligand 1 (PD-L1)
25%
High-risk Neuroblastoma
25%
B Cells
25%
Immune Checkpoint
25%
Syngeneic Model
25%
NKT Cells
25%
Combination Strategy
25%
Immunotherapy Efficacy
25%
Immunotherapeutics
25%
Pediatric Patients
25%
Promising Target
25%
Poor Survival
25%
Treatment Options
25%
Post-chemotherapy
25%
Chemotherapy Resistance
25%
Survival Rate
25%
Effective Treatment
25%
Interaction Analysis
25%
T Cells
25%
Reduced Cytotoxicity
25%
Relapse Prevention
25%
Natural Killer Cells
25%
Tumor
25%
PD-1 Blockade
25%
Medicine and Dentistry
RNA Sequence
100%
Ganglioneuroblastoma
100%
Immunotherapy
100%
Programmed Death-Ligand 1
40%
T Cell
40%
Chemotherapy
40%
Survival Rate
20%
Immunosuppressive Drug
20%
Neoplasm
20%
Natural Killer Cell
20%
Cytotoxicity
20%
B Cell
20%
Natural Killer Cell
20%
Pediatrics Patient
20%
Side Effect
20%
Immunity
20%
Immunology and Microbiology
Immunotherapy
100%
RNA Sequence
100%
Programmed Death-Ligand 1
66%
Natural Killer T Cell
33%
T Cell
33%
Survival Rate
33%
Myeloid
33%
Syngenic
33%
B Cell
33%
Immunosuppressive Drug
33%
Natural Killer Cell
33%
Cytotoxicity
33%
Immunity
33%
